Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/5584_2017_112
Reference49 articles.
1. Barbato A, Russo P, Siani A et al (2004) Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens 22:1895–1901
2. Bauer JA, Fung HL (1991) Concurrent hydralazine administration prevents nitroglycerin- induced hemodynamic tolerance in experimental heart failure. Circulation 84:35–39
3. Calderone A, Thaik CM, Takahashi N, Chang DL, Colucci WS (1998) Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 101:812–818
4. Carson P, Johnson G, Fletcher R, Cohn JN, for the V-HEFT Cooperative Study Group (1996) Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT). J Am Coll Cardiol 27:642–649
5. Carson P, Ziesche S, Johnson G, Cohn JN, for the Vasodilator-Heart Failure Trial Study Group (1999) Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. J Card Fail 5:178–187
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hidralazina e Dinitrato de Isossorbida na Insuficiência Cardíaca: Da Evidência à Prática Clínica;ABC Heart Failure & Cardiomyopathy;2024-07-22
2. Heart failure care in the Central and Eastern Europe and Baltic region: status, barriers, and routes to improvement;ESC Heart Failure;2024-03-22
3. Hydralazine and Isosorbide Dinitrate in Heart Failure: From Evidence to Clinical Practice;ABC Heart Fail Cardiomyop;2024
4. Targeting mitochondrial shape: at the heart of cardioprotection;Basic Research in Cardiology;2023-11-13
5. Hydralazine combined with conventional therapy improved outcomes in severe systolic dysfunction and mitral regurgitation;ESC Heart Failure;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3